Zecotek Photonics (ZMSPF) 0.3002 $ZMSPF
Zecotek Issued U.S. Notice of Allowance for Micro-Pixel Avalanche Photo Transistor
Newsfile Corp - Tue Oct 06, 8:02AM CDT
full story)
ZMS.VN: 0.375 (-0.020)
Pizza Pizza Royalty Corp. Announces September Dividend
Marketwired - Thu Sep 24, 8:02AM CDT
Pizza Pizza Royalty Corp. (TSX: PZA) today announced its monthly cash dividend of $0.068 per share for September 2015.
PZA.TO: 13.32 (-0.02), ZMS.VN: 0.375 (-0.020)
CERN's Compact Muon Solenoid Group at the University of Virginia Orders Zecotek's Thin LFS Crystal Plates
Newsfile Corp - Thu Sep 24, 8:01AM CDT
full story)
ZMS.VN: 0.375 (-0.020)
University of California Successfully Tests Zecotek's LFS Scintillation Crystals for High Resolution Positron Emission Tomography Scanning
GlobeNewswire - Thu Sep 17, 8:25AM CDT
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to announce that the University of California at Davis has successfully tested its patented LFS scintillation crystals in a new cutting edge approach for positron emission tomography (PET) scanning.
ZMS.VN: 0.375 (-0.020)
Zecotek Announces Expansion in Manufacture and Proprietary Process for LFS Crystal Array Assembly
GlobeNewswire - Wed Sep 09, 8:02AM CDT
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced a breakthrough manufacturing process that uses robotics for assembling LFS crystal arrays. The new process results in faster production of the crystal arrays with exceptional accuracy and uniformity.
ZMS.VN: 0.375 (-0.020)
Zecotek Announces Preliminary Revenue for Fiscal 2015
GlobeNewswire - Thu Aug 20, 8:39AM CDT
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced preliminary unaudited revenue for fiscal 2015 ended July 31, 2015.
ZMS.VN: 0.375 (-0.020)
Zecotek Photonics Proposes to Amend Warrants
ACCESSWIRE - Wed Aug 19, 7:12PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / August 19, 2015 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I.F), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that it proposes to amend the terms of an aggregate of 2,983,469 warrants issued to subscribers of a private placement which closed on September 5, 2013. The Company proposes to re-price the exercise price of the subscriber warrants to $0.55 per common share from the initial exercise price of $0.75, and extend the expiry date from September 5, 2015 to March 5, 2016.
ZMS.VN: 0.375 (-0.020)
Zecotek Display Systems Signs Agreements to Commercialize 3D Display Monitors in Russia and CIS Countries
PR Newswire - Wed Aug 12, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced its wholly owned subsidiary, Zecotek Display Systems Pte Ltd., has signed agreements with the Engineering Centre of the National Research Nuclear Center MEPhi (ECM) and its business affiliate Novilab Mobile LLC., to commercialize Zecotek's patented 3D auto-stereoscopic display monitors in Russia and countries of the Commonwealth of Independent States (CIS). The agreements offer ECM and Novilab exclusive rights to the Russian 3D display market. In return ECM and Novilab will be responsible to fund the manufacturing technology transfer of the existing 3D display technology to a final product, and to commercialize the final product for specialized high-end markets in Russia.
ZMS.VN: 0.375 (-0.020)
Zecotek Issued U.S. Notice of Allowance for Rear-Projection Autostereoscopic 3D Display System
PR Newswire - Tue Aug 04, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the U.S. Patent office has issued a Notice of Allowance related to the Company's rear-projection 3D display. The U.S. patent number will be granted in the near future. This notice adds to the significant portfolio of patents, including U.S. patent numbers 7,944,465 and 9,055,288 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.375 (-0.020)
Global Biophotonics Market 2015-2019 - Advancement in Photonic Technology is a Key Market Trend
M2 - Fri Jul 31, 8:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c3sg94/global) has announced the addition of the "Global Biophotonics Market 2015-2019" report to their offering. surface imaging, inside imaging, see-through imaging, optical microscopy, spectro molecular, biosensors, medical lasers and others. The authorpredicts that the global biophotonics testing market will grow at a CAGR of 9.40% during 2015-2019. In this report, The authorcovers the present scenario and growth prospects of the global biophotonics market during 2015-2019. To calculate the market size, the report considers the revenue generated from the various applications of biophotonics. The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the global biophotonics testing market. The vendor landscape in this report focuses primarily on the vendors that provide biophotonics products. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market as a whole, as well as the key trends emerging in the market. Photonics technology is the science to generate, emit, transmit, and detect light. It includes light sources, transmission media, amplifiers, detectors, and modulators. The primary light source used in biophotonics is a laser. The laser devices are faster and more sensitive and accurate for the diagnosis of diseases. For instance, multiphoton imaging uses an ultrafast laser with full 3D resolution that gives accurate results. The combination of imaging modalities, accurate ultrasound, photoacoustic imaging, and optical intelligibility tomography has led to the development of a single 0.19-inch biophotonics device. Key Vendors - Becton, Dickinson and Company - Carl Zeiss - Olympus - Hamamatsu Photonics Other Prominent Vendor - AdvanDx - BIOLASE Technology - BioTek Instruments - EndraLife Sciences - HORIBA - Lumenis - Newport - PerkinElmer - PicoQuant - TILL Photonics - Zecotek Photonics Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Scope of the Report 4. Market Research Methodology 5. Introduction 6. Market Landscape 7. Biophotonics: An Overview 8. Market Segmentation by Application 9. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor For more information visit http://www.researchandmarkets.com/research/c3sg94/global
PKI: 48.19 (+0.31)
Biophotonics - Global Strategic Business Report 2015: Medical (Therapeutics, Diagnostics, & Others), and Non-Medical
M2 - Wed Jul 15, 2:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d7g95g/biophotonics) has announced the addition of the "Biophotonics - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Biophotonics in US$ Million by the following End-Use Sectors: Medical (Therapeutics, Diagnostics, & Others), and Non-Medical. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 85 companies including many key and niche players such as - AdvanDx, Inc. (US) - Affymetrix, Inc. (US) - Andor Technology plc (Ireland) - Becton, Dickinson and Company (US) - BioTek Instruments, Inc. (US) - BIOLASE, Inc. (US) - Carl Zeiss MicroImaging GmbH (Germany) - CEA-Leti (France) - Endra, Inc. (US) - Epi-Light Limited (Ireland) - FEI Company (US) - Glenbrook Technologies, Inc. (US) - Hamamatsu Photonics K.K. (Japan) - HORIBA, Ltd. (Japan) - Lumenis Ltd. (Israel) - Newport Corporation (US) - Ocean Optics, Inc. (US) - Olympus America, Inc. (US) - PerkinElmer, Inc. (US) - Photocure ASA (Norway) - PicoQuant GmbH (Germany) - Solta Medical, Inc. (US) - Zecotek Photonics, Inc. (Singapore) - Zenalux Biomedical, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS, ISSUES AND DRIVERS 3. AN INTRODUCTION TO BIOPHOTONICS 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 85 (including Divisions/Subsidiaries 88) - The United States (45) - Canada (5) - Japan (4) - Europe (30) - - France (3) - - Germany (9) - - The United Kingdom (3) - - Spain (2) - - Rest of Europe (13) - Asia-Pacific (Excluding Japan) (2) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/d7...ophotonics
NEWP: 14.68 (-0.12), LMNS: 13.76 (+0.04), BIOL: 1.02 (+0.07), PKI: 48.19 (+0.31), AFFX: 8.71 (-0.04), FEIC: 77.20 (-0.02)
Zecotek Granted Patent from Japanese Patent Office for its 3D Display Technology
PR Newswire - Wed Jul 08, 8:57AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Japanese Patent Office has issued a patent to Zecotek for technology related to the Company's switchable 3D/2D optical imaging system. This patent adds to the global portfolio of patents, including U.S. patent number 7,944,465 and U.S. patent number 9,055,288 granted in June 2015 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.375 (-0.020)
Zecotek Issued U.S. Notice of Allowance for Micro-Pixel Avalanche Photo Transistor
Newsfile Corp - Tue Oct 06, 8:02AM CDT
full story)
ZMS.VN: 0.375 (-0.020)
Pizza Pizza Royalty Corp. Announces September Dividend
Marketwired - Thu Sep 24, 8:02AM CDT
Pizza Pizza Royalty Corp. (TSX: PZA) today announced its monthly cash dividend of $0.068 per share for September 2015.
PZA.TO: 13.32 (-0.02), ZMS.VN: 0.375 (-0.020)
CERN's Compact Muon Solenoid Group at the University of Virginia Orders Zecotek's Thin LFS Crystal Plates
Newsfile Corp - Thu Sep 24, 8:01AM CDT
full story)
ZMS.VN: 0.375 (-0.020)
University of California Successfully Tests Zecotek's LFS Scintillation Crystals for High Resolution Positron Emission Tomography Scanning
GlobeNewswire - Thu Sep 17, 8:25AM CDT
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to announce that the University of California at Davis has successfully tested its patented LFS scintillation crystals in a new cutting edge approach for positron emission tomography (PET) scanning.
ZMS.VN: 0.375 (-0.020)
Zecotek Announces Expansion in Manufacture and Proprietary Process for LFS Crystal Array Assembly
GlobeNewswire - Wed Sep 09, 8:02AM CDT
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced a breakthrough manufacturing process that uses robotics for assembling LFS crystal arrays. The new process results in faster production of the crystal arrays with exceptional accuracy and uniformity.
ZMS.VN: 0.375 (-0.020)
Zecotek Announces Preliminary Revenue for Fiscal 2015
GlobeNewswire - Thu Aug 20, 8:39AM CDT
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced preliminary unaudited revenue for fiscal 2015 ended July 31, 2015.
ZMS.VN: 0.375 (-0.020)
Zecotek Photonics Proposes to Amend Warrants
ACCESSWIRE - Wed Aug 19, 7:12PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / August 19, 2015 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I.F), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that it proposes to amend the terms of an aggregate of 2,983,469 warrants issued to subscribers of a private placement which closed on September 5, 2013. The Company proposes to re-price the exercise price of the subscriber warrants to $0.55 per common share from the initial exercise price of $0.75, and extend the expiry date from September 5, 2015 to March 5, 2016.
ZMS.VN: 0.375 (-0.020)
Zecotek Display Systems Signs Agreements to Commercialize 3D Display Monitors in Russia and CIS Countries
PR Newswire - Wed Aug 12, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced its wholly owned subsidiary, Zecotek Display Systems Pte Ltd., has signed agreements with the Engineering Centre of the National Research Nuclear Center MEPhi (ECM) and its business affiliate Novilab Mobile LLC., to commercialize Zecotek's patented 3D auto-stereoscopic display monitors in Russia and countries of the Commonwealth of Independent States (CIS). The agreements offer ECM and Novilab exclusive rights to the Russian 3D display market. In return ECM and Novilab will be responsible to fund the manufacturing technology transfer of the existing 3D display technology to a final product, and to commercialize the final product for specialized high-end markets in Russia.
ZMS.VN: 0.375 (-0.020)
Zecotek Issued U.S. Notice of Allowance for Rear-Projection Autostereoscopic 3D Display System
PR Newswire - Tue Aug 04, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the U.S. Patent office has issued a Notice of Allowance related to the Company's rear-projection 3D display. The U.S. patent number will be granted in the near future. This notice adds to the significant portfolio of patents, including U.S. patent numbers 7,944,465 and 9,055,288 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.375 (-0.020)
Global Biophotonics Market 2015-2019 - Advancement in Photonic Technology is a Key Market Trend
M2 - Fri Jul 31, 8:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c3sg94/global) has announced the addition of the "Global Biophotonics Market 2015-2019" report to their offering. surface imaging, inside imaging, see-through imaging, optical microscopy, spectro molecular, biosensors, medical lasers and others. The authorpredicts that the global biophotonics testing market will grow at a CAGR of 9.40% during 2015-2019. In this report, The authorcovers the present scenario and growth prospects of the global biophotonics market during 2015-2019. To calculate the market size, the report considers the revenue generated from the various applications of biophotonics. The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the global biophotonics testing market. The vendor landscape in this report focuses primarily on the vendors that provide biophotonics products. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market as a whole, as well as the key trends emerging in the market. Photonics technology is the science to generate, emit, transmit, and detect light. It includes light sources, transmission media, amplifiers, detectors, and modulators. The primary light source used in biophotonics is a laser. The laser devices are faster and more sensitive and accurate for the diagnosis of diseases. For instance, multiphoton imaging uses an ultrafast laser with full 3D resolution that gives accurate results. The combination of imaging modalities, accurate ultrasound, photoacoustic imaging, and optical intelligibility tomography has led to the development of a single 0.19-inch biophotonics device. Key Vendors - Becton, Dickinson and Company - Carl Zeiss - Olympus - Hamamatsu Photonics Other Prominent Vendor - AdvanDx - BIOLASE Technology - BioTek Instruments - EndraLife Sciences - HORIBA - Lumenis - Newport - PerkinElmer - PicoQuant - TILL Photonics - Zecotek Photonics Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Scope of the Report 4. Market Research Methodology 5. Introduction 6. Market Landscape 7. Biophotonics: An Overview 8. Market Segmentation by Application 9. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor For more information visit http://www.researchandmarkets.com/research/c3sg94/global
PKI: 48.19 (+0.31)
Biophotonics - Global Strategic Business Report 2015: Medical (Therapeutics, Diagnostics, & Others), and Non-Medical
M2 - Wed Jul 15, 2:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d7g95g/biophotonics) has announced the addition of the "Biophotonics - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Biophotonics in US$ Million by the following End-Use Sectors: Medical (Therapeutics, Diagnostics, & Others), and Non-Medical. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 85 companies including many key and niche players such as - AdvanDx, Inc. (US) - Affymetrix, Inc. (US) - Andor Technology plc (Ireland) - Becton, Dickinson and Company (US) - BioTek Instruments, Inc. (US) - BIOLASE, Inc. (US) - Carl Zeiss MicroImaging GmbH (Germany) - CEA-Leti (France) - Endra, Inc. (US) - Epi-Light Limited (Ireland) - FEI Company (US) - Glenbrook Technologies, Inc. (US) - Hamamatsu Photonics K.K. (Japan) - HORIBA, Ltd. (Japan) - Lumenis Ltd. (Israel) - Newport Corporation (US) - Ocean Optics, Inc. (US) - Olympus America, Inc. (US) - PerkinElmer, Inc. (US) - Photocure ASA (Norway) - PicoQuant GmbH (Germany) - Solta Medical, Inc. (US) - Zecotek Photonics, Inc. (Singapore) - Zenalux Biomedical, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS, ISSUES AND DRIVERS 3. AN INTRODUCTION TO BIOPHOTONICS 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 85 (including Divisions/Subsidiaries 88) - The United States (45) - Canada (5) - Japan (4) - Europe (30) - - France (3) - - Germany (9) - - The United Kingdom (3) - - Spain (2) - - Rest of Europe (13) - Asia-Pacific (Excluding Japan) (2) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/d7...ophotonics
NEWP: 14.68 (-0.12), LMNS: 13.76 (+0.04), BIOL: 1.02 (+0.07), PKI: 48.19 (+0.31), AFFX: 8.71 (-0.04), FEIC: 77.20 (-0.02)
Zecotek Granted Patent from Japanese Patent Office for its 3D Display Technology
PR Newswire - Wed Jul 08, 8:57AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Japanese Patent Office has issued a patent to Zecotek for technology related to the Company's switchable 3D/2D optical imaging system. This patent adds to the global portfolio of patents, including U.S. patent number 7,944,465 and U.S. patent number 9,055,288 granted in June 2015 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.375 (-0.020)
